FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Losartan Potassium/HCTZ Recall

Losartan Potassium/HCTZ, 100 mg/12

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
May 8, 2019
Recall ID
D-1270-2019
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Losartan Potassium/HCTZ starting Apr 22, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1270-2019 on May 8, 2019. Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million. Status: Terminated.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.

Product description

Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.

Lot numbers, UPCs & expiration codes

Lot #: B0517068-101618, Exp. Date: 10/2019

Where it was sold

Product was distributed to Florida.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1270-2019
Classification
Class II
Status
Terminated
Recall initiated
Apr 22, 2019
FDA report date
May 8, 2019
Quantity
44 HDPE bottles of 90 = 3,960 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-1270-2019, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
82748
Address
625 Kolter Dr Ste 4
Code information
Lot #: B0517068-101618, Exp. Date: 10/2019
Postal code
15701-3571
Report date
May 8, 2019
Product type
Drugs
Recall number
D-1270-2019
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
44 HDPE bottles of 90 = 3,960 tablets
Termination date
May 19, 2020
Reason for recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.
Distribution pattern
Product was distributed to Florida.
Recall initiation date
Apr 22, 2019
Initial firm notification
Letter
Center classification date
May 2, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1270-2019, published May 8, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls